Abstract
Tu1298 Anti-Infliximab Antibodies With Neutralizing Capacity in Inflammatory Bowel Disease Patients: Distinct Clinical Implications Revealed by a Novel Assay
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have